Comparison of bacteriologic eradication of Streptococcus pneumoniae by clarithromycin and reports of increased antimicrobial resistance

Bartlett, 1995, Community-acquired pneumonia, N Engl J Med., 333, 1618, 10.1056/NEJM199512143332408 Reynolds, 1995, Chronic bronchitis and acute infectious exacerbations, 608 Lark, 1999, Antimicrobial resistance in community-acquired respiratory tract pathogens, Compr Ther., 25, 20, 10.1007/BF02889831 DeAbate, 1999, Efficacy and tolerability of oncedaily grepafloxacin compared to clarithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis, Clin Drug Invest., 17, 21, 10.2165/00044011-199917010-00003 Anzuelo, 1998, Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: Ciprofloxacin 750 mg BID versus clarithromycin 500 mg BID, Clin Ther., 20, 1 Williams, 1988, Immunization policies and vaccine coverage among adults, Ann Intern Med., 108, 616, 10.7326/0003-4819-108-4-616 Ruiz-Gonzalez, 1999, Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia, Am J Med., 106, 385, 10.1016/S0002-9343(99)00050-9 Saint, 1995, Antibiotics in chronic obstructive pulmonary disease exacerbations, JAMA, 273, 957, 10.1001/jama.273.12.957 DeBock, 1997, Antimicrobial treatment in acute maxillary sinusitis: A metaanalysis, J Clin Epidemial., 50, 881, 10.1016/S0895-4356(97)00117-0 Ziering, 1998, Randomized comparison of oncedaily ceftibuten and twice-daily clarithromycin in the treatment of acute exacerbation of chronic bronchitis, Infection, 26, 72, 10.1007/BF02768764 Doern, 1998, Mechanisms and current rates of resistance, Am J Managed Care, 4, S531 Bachand, 1991, Comparative study of clarithromycin and ampicillin in the treatment of patients with acute bacterial exacerbations of chronic bronchitis, J Antimicrob Chemother., 27, 91, 10.1093/jac/27.suppl_A.91 Aldons, 1991, A comparison of clarithromycin with ampicillin in the treatment of outpatients with acute bacterial exacerbation of chronic bronchitis, J Antimicrob Chemother., 27, 101, 10.1093/jac/27.suppl_A.101 Poirer, 1991, Comparative study of clarithromycin and roxithromycin in the treatment of community-acquired pneumonia, J Antimicrob Chemother., 27, 109, 10.1093/jac/27.suppl_A.109 Guay, 1992, Comparative safety and efficacy of clarithromycin and ampicillin in the treatment of out-patients with acute bacterial exacerbation of chronic bronchitis, J Intern Med., 23, 295, 10.1111/j.1365-2796.1992.tb00538.x Appelbaum, 1992, Antimicrobial resistance in Streptococcus pneumoniae: An overview, Clin Infect Dis., 15, 77, 10.1093/clinids/15.1.77 Kislak, 1965, Susceptibility of pneumococci to nine antibiotics, Am J Med Sci., 250, 261, 10.1097/00000441-196509000-00003 Jorgensen, 1990, Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States, Antimicrob Agents Chemother., 34, 2075, 10.1128/AAC.34.11.2075 Spika, 1991, Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979—1987, J Infect Dis., 163, 1273, 10.1093/infdis/163.6.1273 Barry, 1994, In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. medical centers in 1992 and 1993, Antimicrob Agents Chemother., 38, 2419, 10.1128/AAC.38.10.2419 Thornsberry, 1996, Activity of penicillin three third-generation cephalosporins against U.S. isolates of Streptococcus pneumoniae: A 1995 surveillance study, Diagn Microbiol Infect Dis., 25, 89, 10.1016/S0732-8893(96)00098-3 Doem, 1996, Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: Results of a 30-center national surveillance study, Antimicrob Agents Chemother., 40, 1208, 10.1128/AAC.40.5.1208 Jones, 1998, In vitro evaluation of sparfloxacin activity and spectrum against 24,940 pathogens isolated in the United States and Canada, the final analysis, Diagn Microbiol Infect Dis., 31, 313, 10.1016/S0732-8893(97)00247-2 Thornsberry, 1997, Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996–1997 respiratory season, Diagn Microbiol Infect Dis., 29, 249, 10.1016/S0732-8893(97)00195-8 Doern, 1998, Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program, Clin Infect Dis., 27, 764, 10.1086/514953 Thornsberrry, 1993, Increasing penicillin resistance in Streptococcus pneumoniae in the U.S., Infect Med., 93, 15 Chodosh, 1998, Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis, Clin Infect Dis., 27, 730, 10.1086/514934 1997 Gerardo, 1996, Comparison of Etest to broth microdilution method for testing Streptococcus pneumoniae susceptibility to levofloxacin and three macrolides, Antimicrob Agents Chemother., 40, 2413, 10.1128/AAC.40.10.2413 Goldstein, 1999, Comparative in vitro activities of amoxicillin-clavulanate against aerobic and anaerobic bacteria isolated from antral puncture specimens from patients with sinusitis, Antimicrob Agents Chemother., 43, 705, 10.1128/AAC.43.3.705 Retsema, 1991, Effects of environmental factors on the in vitro potency of azithromycin, Eur J Clin Microbiol Infect Dis., 10, 834, 10.1007/BF01975836 Shortridge, 1998, Streptococcus pneumoniae susceptibility testing with clarithromycin: Comparison of reference broth microdilution method to Etest Tramont, 1995, General or non-specific host defense mechanisms, 30 Gotfried, 1999, In vitro Streptococcus pneumoniae (SP) resistance: Correlation with outcomes in patients with respiratory infections, J Antimicrob Chemother., 44, 83 Conte, 1995, Intrapulmonary pharmacokinetics of clarith-romycin and of erythromycin, Antimicrob Agents Chemother., 39, 334, 10.1128/AAC.39.2.334 Conte, 1996, Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects, Antimicrob Agents Chemother., 40, 1617, 10.1128/AAC.40.7.1617 Rodvold, 1997, Intrapulmonary steadystate concentrations of clarithromycin and azithromycin in healthy adult volunteers, Antimicrob Agents Chemother., 41, 1399, 10.1128/AAC.41.6.1399